Noveldx
3 known investors
Novel Microdevices develops a portable, battery-powered point-of-care molecular diagnostic system that runs PCR-based nucleic acid amplification on disposable cartridges to detect pathogens and antibiotic-resistance mutations in about 15 minutes. The system targets same-visit testing and diagnosis, with an emphasis on low-resource settings and low- and middle-income countries.
Founders & leadership
Investors · 3
Competitors · 5
by search overlap
Foresight Dx6 shared keywordsForesight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.
Molecular Devices6 shared keywordsMolecular Devices develops laboratory instruments and automated workflows for life science research, including SpectraMax microplate readers, high-content screening and imaging systems, colony-picking devices, and 3D organoid and cell culture solutions. It serves researchers in drug discovery, cell line development, and screening, supported by AI-enabled analysis software and GxP compliance tools.
Labcorp5 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
AmplifiDx4 shared keywordsAmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients. The multiplex platform can detect up to 10 analytes with rapid results and minimal hands-on time.
Galaxy Diagnostics4 shared keywords
Companies competing with Noveldx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Noveldx do?
- Novel Microdevices develops a portable, battery-powered point-of-care molecular diagnostic system that runs PCR-based nucleic acid amplification on disposable cartridges to detect pathogens and antibiotic-resistance mutations in about 15 minutes. The system targets same-visit testing and diagnosis, with an emphasis on low-resource settings and low- and middle-income countries.
- Who founded Noveldx?
- Noveldx was founded by Andrea Pais, Rohan Pais.
- Who are Noveldx's investors?
- Noveldx's investors include Maryland TEDCO, Old Line Capital Partners, TEDCO.